WAVELY DIAGNOSTICS INC
Smartphone-based otoscope application for at-home ear infection diagnosis
- Sector
- Medtech
- Headquarters
- Seattle, WA
- Founded
- 2018
- Latest Form D
- $258K, Aug 2022
- Total capital
- $6.2M
- Federal grants
- $5.9M
- 7 awards · 2019–2026
- Rank in peer group#119 of 477
- Private capital raised
- $258K
- 1 Form D · last Aug 2022
- 51 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Improving Rural Access to Pediatric Health Care with Accurate Telehealth Diagnosis of Acute Otitis Media via Wide Scale Use of Smartphone Acoustic Reflectometry$992K
- Federal grantHealth and Human S · Phase II · Improving Rural Access to Pediatric Health Care with Accurate Telehealth Diagnosis of Acute Otitis Media via Wide Scale Use of Smartphone Acoustic Reflectometry$1.1M
- Federal grantHealth and Human S · Phase II · Improving Rural Access to Pediatric Healthcare with Accurate Telehealth Diagnosis of Acute Otitis Media using Smartphone Acoustic Reflectometry$860K
- Federal grantHealth and Human S · Phase II · Improving Rural Access to Pediatric Healthcare with Accurate Telehealth Diagnosis of Acute Otitis Media using Smartphone Acoustic Reflectometry$933K
- Federal grantHealth and Human S · Phase II · Improving Rural Access to Pediatric Healthcare with Accurate Telehealth Diagnosis of Acute Otitis Media using Smartphone Acoustic Reflectometry$1.8M
- Private capital raisedForm D · SEC · 1st filing$258K
- Federal grantHealth and Human S · Phase I · Detecting Middle Ear Fluid Using Smartphones$66K
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Detecting Middle Ear Fluid Using Smartphones$158K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
35months
from WAVELY DIAGNOSTICS INC’s first federal award to its first private round.
- First federal award · Aug 2019
- Health and Human S · $158K
- First Form D · Aug 2022
- $258K · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#119 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Arna Ionescu StollResearcherExecutive Officer, Director, PromoterLinked by $1.8M in grants as PI
- Shyamnath Ionescu GollakotaResearcherDirector, PromoterLinked by $158K in grants as PI
- Ehud Ionescu GelblumExecutive OfficerNamed in SEC Form D filings
- Jud Ionescu HeugelExecutive OfficerNamed in SEC Form D filings
- Missy Ionescu KrasnerDirectorNamed in SEC Form D filings
- Naomi Ionescu FriedDirectorNamed in SEC Form D filings
Show all 7 people
- Randall Ionescu BlyDirector, PromoterNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- CONTROLPOINT INC.Similar federal contract value in Medtech · null in contracts
- On Target Laboratories, Inc.Similar federal contract value in Medtech · null in contracts
- Harbinger HealthSimilar federal contract value in Medtech · null in contracts
- LARIAT BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- APTUS BIOSCIENCES LLCSimilar federal contract value in Medtech · null in contracts
- Alaunus BiosciencesSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .